Global Intelligence Database
A new review highlights how optimising existing renin-angiotensin system (RAS) therapies creates a stable biological baseline. This allows clinicians to safely stack newer medications, fundamentally changing how we manage renal decline.
By Vitiello, Ponzo, Boccellino, Zovi
Researchers measured genetic fragments in blood plasma to see if they could reliably identify cancer. They found that while these fragments vary wildly between individuals, simply counting the total number of highly abnormal genes can distinguish cancer patients from healthy donors.
By Morlion, Decruyenaere, Schoofs, Anckaert, Johns Ramirez, Nuytens, Vanden Eynde, Verniers, Everaert, Brusselle, Callens, Haerynck, Hemelsoet, Hoste, Lambert, Lumen, Offner, Paemeleire, Smith, Van den Eynde, Van Dorpe, Vanhaecke, Van Vlierberghe, Mariman, Thas, Vandesompele, Mestdagh
For decades, doctors have relied on a flawed metric to estimate kidney function. A comprehensive review suggests that a protein called Cystatin C offers a more accurate alternative, potentially improving early detection for millions.
By Patel S, Dhalani M, Reddy M, Ruhela N, Jain R, Kaur G.